X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6480) 6480
Book Review (2779) 2779
Publication (721) 721
Book Chapter (90) 90
Book / eBook (15) 15
Conference Proceeding (13) 13
Dissertation (4) 4
Magazine Article (1) 1
Paper (1) 1
Reference (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (5307) 5307
humans (4807) 4807
oncology (3055) 3055
cancer (2583) 2583
male (1876) 1876
female (1686) 1686
metastasis (1624) 1624
animals (1451) 1451
metastatic breast-cancer (1254) 1254
middle aged (1175) 1175
care and treatment (1159) 1159
aged (1128) 1128
tumors (1056) 1056
chemotherapy (1031) 1031
metastatic melanoma (1030) 1030
research (901) 901
immunotherapy (841) 841
prostate cancer (777) 777
metastatic colorectal-cancer (757) 757
adult (753) 753
health aspects (743) 743
prognosis (693) 693
neoplasms - drug therapy (691) 691
antineoplastic agents - therapeutic use (675) 675
medicine & public health (667) 667
pharmacology & pharmacy (657) 657
analysis (644) 644
carcinoma (620) 620
breast cancer (617) 617
survival (604) 604
treatment outcome (594) 594
breast-cancer (591) 591
melanoma (566) 566
cell line, tumor (564) 564
mice (556) 556
prostate-cancer (539) 539
expression (535) 535
cell lung-cancer (532) 532
aged, 80 and over (520) 520
neoplasm metastasis (515) 515
article (498) 498
immunology (495) 495
neoplasms - therapy (487) 487
cell biology (484) 484
review (471) 471
metastases (469) 469
cancer therapies (465) 465
development and progression (461) 461
neoplasms - pathology (418) 418
therapy (418) 418
clinical trials (417) 417
diagnosis (417) 417
drug therapy (417) 417
medicine, research & experimental (407) 407
pathology (407) 407
patients (390) 390
phase-ii trial (388) 388
surgery (386) 386
cancer research (384) 384
antineoplastic agents - pharmacology (380) 380
neoplasms - immunology (378) 378
clinical trials as topic (376) 376
lung-cancer (372) 372
prostatic neoplasms - pathology (370) 370
urology & nephrology (365) 365
immunohistochemistry (361) 361
genetic aspects (360) 360
apoptosis (358) 358
biochemistry & molecular biology (344) 344
medical research (341) 341
proteins (339) 339
angiogenesis (332) 332
medicine (331) 331
gene expression (321) 321
disease progression (309) 309
peripheral-blood (308) 308
antibodies, monoclonal - therapeutic use (306) 306
dendritic cells (306) 306
antineoplastic combined chemotherapy protocols - therapeutic use (297) 297
colorectal cancer (297) 297
biomarkers (294) 294
renal-cell carcinoma (291) 291
in-vivo (285) 285
breast neoplasms - pathology (284) 284
hematology, oncology and palliative medicine (280) 280
colorectal-cancer (276) 276
physiological aspects (276) 276
abridged index medicus (275) 275
radiotherapy (271) 271
usage (266) 266
bone neoplasms - secondary (262) 262
endothelial growth-factor (262) 262
growth-factor receptor (262) 262
mutation (261) 261
neoplasms - metabolism (261) 261
antigens (260) 260
neoplasm staging (259) 259
retrospective studies (259) 259
risk factors (259) 259
studies (257) 257
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6476) 6476
German (28) 28
French (23) 23
Japanese (14) 14
Spanish (11) 11
Turkish (3) 3
Dutch (2) 2
Korean (2) 2
Polish (2) 2
Chinese (1) 1
Hungarian (1) 1
Indonesian (1) 1
Italian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Letters, ISSN 0304-3835, 12/2017, Volume 410, pp. 100 - 111
Extracellular vesicles released from cancer cells may play an important role in cancer progression by shuttling oncogenic information into recipient cells.... 
Extracellular vesicles | TGFβ | Micro-RNAs | Prostate cancer | EMT | METASTATIC-DISEASE | RECEPTOR | MECHANISMS | LARGE ONCOSOMES | ANDROGEN-DEPRIVATION THERAPY | BREAST-CANCER | TRANSITION | HETEROGENEITY | ONCOLOGY | EXOSOMES | TGF beta | CANCER PROGRESSION | Neoplasms, Hormone-Dependent - metabolism | Prostatic Neoplasms - metabolism | Humans | Receptors, Androgen - metabolism | Transforming Growth Factor beta1 - metabolism | Tumor Microenvironment | Drug Resistance, Neoplasm | Epithelial-Mesenchymal Transition - drug effects | Male | Neoplasms, Hormone-Dependent - genetics | Dose-Response Relationship, Drug | Prostatic Neoplasms - genetics | Receptors, Androgen - drug effects | Cell-Derived Microparticles - drug effects | Time Factors | Cell-Derived Microparticles - pathology | Cell-Derived Microparticles - metabolism | Prostatic Neoplasms - drug therapy | Prostatic Neoplasms - pathology | Antineoplastic Agents, Hormonal - pharmacology | Neoplasm Invasiveness | Androgen Antagonists - pharmacology | Transforming Growth Factor beta1 - genetics | Phenotype | Receptors, Androgen - genetics | Signal Transduction - drug effects | Neoplasms, Hormone-Dependent - pathology | Cell Line, Tumor | Neoplasms, Hormone-Dependent - drug therapy | Cell Movement | Development and progression | Transforming growth factors | Stem cells | Metastasis | Prostate carcinoma | Transformation | Mesenchyme | Invasiveness | Signalling | Nanoparticles | Signal transduction | Vesicles | Androgens | Prostate | Communication | Cancer | Index Medicus
Journal Article
American journal of clinical oncology, ISSN 0277-3732, 01/2019, Volume 42, Issue 1, pp. 99 - 106
Painful osseous metastasis resulting from castration-resistant prostate carcinoma is a common clinical problem. Historically, nuclear medicine offered several... 
nuclear medicine therapies | radium | metastatic castration-resistant prostate carcinoma | Dosage and administration | Research | Castration | Drug therapy | Drug resistance | Prostate cancer
Journal Article
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, ISSN 0277-3732, 01/2019, Volume 42, Issue 1, pp. 99 - 106
Painful osseous metastasis resulting from castration-resistant prostate carcinoma is a common clinical problem. Historically, nuclear medicine offered several... 
CANCER PATIENTS | radium | metastatic castration-resistant prostate carcinoma | MANAGEMENT | nuclear medicine therapies | OPEN-LABEL | ALPHA-THERAPY | RADIATION-THERAPY | ONCOLOGY | RADIOLIGAND THERAPY | BONE-SEEKING RADIOPHARMACEUTICALS | RADIUM-223 CHLORIDE | SKELETAL-RELATED EVENTS | TARGETED AGENTS
Journal Article
Journal Article
Pathobiology, ISSN 1015-2008, 11/2018, Volume 85, Issue 5-6, pp. 289 - 299
Journal Article
Oncology Letters, ISSN 1792-1074, 09/2015, Volume 10, Issue 3, pp. 14025 - 1408
The aim of the present study was to investigate the pathogenesis of metastatic prostate carcinoma, to find the metabolic pathways Changed in the disease and to... 
Small molecules | Differentially expressed genes | MicroRNA | Metastatic prostate carcinoma | MORTALITY | SIGNATURES | ONCOLOGY | metastatic prostate carcinoma | differentially expressed genes | microRNA | MUTATIONS | CANCER | small molecules | ALKALOIDS
Journal Article
Journal Article
Cancer, ISSN 0008-543X, 02/2002, Volume 94, Issue 4, pp. 980 - 986
BACKGROUND. The clinical effects of targeting HER-2 in prostate carcinoma are not known. This study explored the feasibility of molecular profiling to... 
Prostate carcinoma | Clinical trial design | HER-2 | Trastuzumab | Paclitaxel | TRANSFORMATION | paclitaxel | POINT MUTATION | NEU ONCOGENE | clinical trial design | trastuzumab | BREAST-CANCER | GROWTH-FACTOR RECEPTOR | C-ERBB-2 PROTEIN | ONCOLOGY | GENE AMPLIFICATION | METASTATIC DISEASE | prostate carcinoma | EXPRESSION | ESTRAMUSTINE
Journal Article
INDIAN JOURNAL OF CANCER, ISSN 0019-509X, 04/2018, Volume 55, Issue 2, pp. 148 - 153
Journal Article
Journal Article
Journal Article